argenx SE
delivering on the promise of continuous value creation consistent execution serial innovation | argenx SE
Company
Deck Type
Sector
Industry
Deck date
July 2023
Slide
14 of 15
Related slides by other companies
Xeris Biopharma
Investor Presentation
October 2022
topline results of phase study of | Xeris Biopharma
Ocuphire Pharma
Results
March 2021
topline phase results randomized parallel arm double masked placebo controlled study of the safety and efficacy of ophthalmic solution to reverse pharmacologically induced mydriasis in healthy subjects | Ocuphire Pharma
Ocuphire Pharma
Results
March 2022
topline phase results | Ocuphire Pharma
Albireo Pharma
Results
October 2022
assert topline data results | Albireo Pharma
Other recent decks by argenx SE
See all presentations (28 decks)
Results
February 2024
Investor Conference
January 2024
Investor Presentation
December 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io